Human papillomavirus vaccine may reduce the rate of oral HPV infections in young adults by as much as 88 percent, studies suggest. However, given the vaccine’s low rate of uptake in the U.S.—especially in males—the impact of the vaccine on oral HPV infections remains low.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe